In the selected studies, participants were supplemented in a dose ranging from 1 g to 4,5 g per day for either 12 or 24 weeks, mostly by L-carnitine-L-tartrate (LCLT)
Similar content being viewed by others Change history 16 November 2011 This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication References Bailey, HH, Mulcahy, RT, Tutsch, KD, Arzoomanian, RZ, Alberti, D, Tombes, MB, Wilding, G, Pomplun, M & Spriggs, DR (1994) Phase I clinical trial of intravenous L-buthionine sulfoximine and melphalan: an attempt at modulation of glutathione
An acute anti-inflammatory and analgetic activity was noted for NaBPC157 (e.g
Dubland JA, Francis GA (2015) Lysosomal acid lipase: at the crossroads of normal and atherogenic cholesterol metabolism
BPC-157 is not intended to diagnose, treat, or cure any medical condition, but may be considered by a licensed provider as part of a customized recovery and wellness plan
Transfusion 61 (Suppl 2), S1s10
